Figure S2 from Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma
Open Access
- 17 March 2025
- other
- Published by American Association for Cancer Research (AACR)